The Food and Drug Administration added automated external defibrillators (AED) to its list of medical devices in short supply. The AED supply disruption reflects both surging demand and problems sourcing a component, part or accessory. For wearable and non-wearable AEDs, the supply disruption is expected to last for the duration of 2022, the FDA said. In a footnote, the FDA added there is a global shortage of semiconductor chips that are essential to some medical devices. The regulator linked to the footnote in its description of the problems with a component, part or accessory that are affecting AEDs. Six entries — two AEDs and four ventilators — are linked to the chip shortage.